Participant Characteristics and HIV Risk Behaviors Among Individuals Entering Integrated Buprenorphine/Naloxone and HIV Care
Authors:
- Amina A ChaudhryACAmina A Chaudhry
- Michael BotskoMBMichael Botsko
- Linda WeissLWLinda Weiss
- James E EganJEJames E Egan
- Jennifer MittyJMJennifer Mitty
- Barbara EstradaBEBarbara Estrada
- Gregory M LucasGLGregory M Lucas
- Tanita WoodsonTWTanita Woodson
- Timothy P FlaniganTFTimothy P Flanigan
- David A FiellinDFDavid A Fiellin
- 1 March 2011
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 56 (Supplement) , S14-S21
Abstract
This study was part of a national, multisite demonstration project evaluating the impact of integrated buprenorphine/naloxone treatment and HIV care. The goals of this study were to describe the baseline demographic, clinical, and substance use characteristics of the participants and to explore HIV transmission risk behaviors in this group. Nine sites across the United States participated. Data obtained by interview and chart review included demographic information, medical history, substance use, and risk behaviors.We performed a descriptive analysis of patient characteristics at entry and used logistic regression to evaluate factors associated with 1) unprotected anal or vaginal sex; and 2) needle-sharing within the previous 90 days. Three hundred eighty-six individuals were included in the study: 303 (78.5%) received buprenorphine/naloxone; 41 (10.6%) received methadone; and 42 (10.9%) received another form of treatment. The analysis of risk behaviors was limited to those in the buprenorphine group (n = 303). Among those reporting vaginal or anal sex in the previous 90 days, 24% had sex without a condom. Factors significantly associated with unprotected sex were: having a partner; female gender; and alcohol use in previous 30 days. A total of 8.9% of participants shared needles in the previous 90 days. Factors significantly associated with needle-sharing were: amphetamine use; marijuana use; homelessness; and anxiety. Addressing transmission risk behaviors is an important secondary HIV prevention strategy. In addition to treatment for opioid dependence, addressing other substance use, social issues, particularly housing, and mental health may have important implications for reducing HIV transmission in HIV-infected opioid-dependent patients.Keywords
This publication has 68 references indexed in Scilit:
- The Impact of Cocaine Use on Outcomes in HIV-Infected Patients Receiving Buprenorphine/NaloxoneJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviorsJournal of Substance Abuse Treatment, 2008
- Health Status, Health Care Use, Medication Use, and Medication Adherence Among Homeless and Housed People Living With HIV/AIDSAmerican Journal of Public Health, 2007
- Hazardous Alcohol UseJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Drug Use and Medication Adherence among HIV-1 Infected IndividualsAIDS and Behavior, 2006
- Crystal Methamphetamine, Its Analogues, and HIV Infection: Medical and Psychiatric Aspects of a New EpidemicClinical Infectious Diseases, 2004
- Alcohol use and serial monogamy as risks for sexually transmitted diseases in young adults.Health Psychology, 2002
- Alcohol use and contraception in first sexual experiencesJournal of Behavioral Medicine, 1995
- Screening for Psychiatric Morbidity in a Medical Outpatient Clinic for HIV Infection: The Need for a Psychiatric PresenceThe International Journal of Psychiatry in Medicine, 1994
- The CES-D ScaleApplied Psychological Measurement, 1977